# Penpulimab kcqx

NDC: 83654-105
Generic name: Penpulimab
Labeler / Manufacturer: Akeso Biopharma, Co., Ltd
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Biologic License Application
Dosage form: INJECTION
Routes: INTRAVENOUS
Marketing started: 20250423

FDA application: BLA761258

## Active ingredients

- PENPULIMAB: 100 mg/10mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"83654-105"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=83654-105
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=830004e8-31af-4cc6-ab16-e870cab1c5ca